Pekin Hardy Strauss’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,700
Closed -$2.06M 466
2025
Q3
$2.06M Buy
2,700
+200
+8% +$149K 0.21% 115
2025
Q2
$1.95M Buy
2,500
+200
+9% +$155K 0.22% 107
2025
Q1
$1.9M Buy
+2,300
New +$1.91M 0.23% 108

Other funds holding LLY

Pekin Hardy Strauss's LLY Position: Q2 2026 in Review

Pekin Hardy Strauss increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $273K and bringing the position to 971 shares worth $1.16M. The position accounts for 0.1% of the portfolio, ranked #201.

Pekin Hardy Strauss first reported a position in LLY in Q2 2015 and has held it in 22 quarters since. The position peaked at $1.36M in Q3 2024. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pekin Hardy Strauss held 971 shares of Eli Lilly worth $1.16M as of Q2 2026.
  • Pekin Hardy Strauss bought 267 Eli Lilly shares in Q2 2026, an estimated $273K.
  • Eli Lilly made up 0.1% of Pekin Hardy Strauss's portfolio in Q2 2026, its #201 holding.
  • Pekin Hardy Strauss first reported a position in Eli Lilly in Q2 2015 and has held it in 22 quarters since.
  • Pekin Hardy Strauss's Eli Lilly position peaked at $1.36M in Q3 2024.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.